AgThera Inc.
AgThera is a biotechnology company focused on developing advanced probiotics and live therapeutics to combat global food insecurity and promote One Health. Their mission is to support sustainable animal protein production by designing innovative solutions using genetic engineering, machine learning, and biomanufacturing. Their products, which include advanced probiotics and antibacterial/antiviral live therapeutics, help farmers raise healthy animals free of pathogens. The company leverages synthetic biology, artificial intelligence, and computational biology to engineer and test these live biotherapeutics for consistent performance. AgThera has received Small Business Innovative Research grants from the US National Science Foundation and USDA for its AI-enabled R&D program. Their platform technology aims to eliminate pathogens in animals, with initial products targeting chicken producers to reduce contamination from salmonella, clostridia, and campylobacter, and future products for swine producers to address E. coli, Lawsonia intracellularis, and Streptococcus suis, as well as antiparasitic and antiviral probiotics.
AgThera Inc.
AgThera is a biotechnology company focused on developing advanced probiotics and live therapeutics to combat global food insecurity and promote One Health. Their mission is to support sustainable animal protein production by designing innovative solutions using genetic engineering, machine learning, and biomanufacturing. Their products, which include advanced probiotics and antibacterial/antiviral live therapeutics, help farmers raise healthy animals free of pathogens. The company leverages synthetic biology, artificial intelligence, and computational biology to engineer and test these live biotherapeutics for consistent performance. AgThera has received Small Business Innovative Research grants from the US National Science Foundation and USDA for its AI-enabled R&D program. Their platform technology aims to eliminate pathogens in animals, with initial products targeting chicken producers to reduce contamination from salmonella, clostridia, and campylobacter, and future products for swine producers to address E. coli, Lawsonia intracellularis, and Streptococcus suis, as well as antiparasitic and antiviral probiotics.